These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 28661031)

  • 21. The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment.
    Mi Y; Guo N; Luan J; Cheng J; Hu Z; Jiang P; Jin W; Gao X
    Front Immunol; 2020; 11():737. PubMed ID: 32391020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloid-derived suppressor cells: The green light for myeloma immune escape.
    Malek E; de Lima M; Letterio JJ; Kim BG; Finke JH; Driscoll JJ; Giralt SA
    Blood Rev; 2016 Sep; 30(5):341-8. PubMed ID: 27132116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic Regulation of Myeloid-Derived Suppressor Cell Function in Cancer.
    Wang Y; Jia A; Bi Y; Wang Y; Liu G
    Cells; 2020 Apr; 9(4):. PubMed ID: 32325683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloid-derived suppressor cells as effectors of immune suppression in cancer.
    Pyzer AR; Cole L; Rosenblatt J; Avigan DE
    Int J Cancer; 2016 Nov; 139(9):1915-26. PubMed ID: 27299510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Myeloid-Derived Suppressor Cells in Tumor Growth and Metastasis.
    Bayik D; Lee J; Lathia JD
    Exp Suppl; 2022; 113():189-217. PubMed ID: 35165865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloid-Derived Suppressor Cells in the Tumor Microenvironment: Current Knowledge and Future Perspectives.
    Ibáñez-Vea M; Zuazo M; Gato M; Arasanz H; Fernández-Hinojal G; Escors D; Kochan G
    Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):113-123. PubMed ID: 29032490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer.
    Law AMK; Valdes-Mora F; Gallego-Ortega D
    Cells; 2020 Feb; 9(3):. PubMed ID: 32121014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
    Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
    Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond.
    Zhao Y; Du J; Shen X
    Front Immunol; 2023; 14():1157537. PubMed ID: 37006306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical immunosuppressive effect of MDSC‑derived exosomes in the tumor microenvironment.
    Rashid MH; Borin TF; Ara R; Piranlioglu R; Achyut BR; Korkaya H; Liu Y; Arbab AS
    Oncol Rep; 2021 Mar; 45(3):1171-1181. PubMed ID: 33469683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reciprocal Signaling between Myeloid Derived Suppressor and Tumor Cells Enhances Cellular Motility and is Mediated by Structural Cues in the Microenvironment.
    Shukla VC; Duarte-Sanmiguel S; Panic A; Senthilvelan A; Moore J; Bobba C; Benner B; Carson WE; Ghadiali SN; Gallego-Perez D
    Adv Biosyst; 2020 Jun; 4(6):e2000049. PubMed ID: 32419350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloid-Derived Suppressor Cells in Solid Tumors.
    Ma T; Renz BW; Ilmer M; Koch D; Yang Y; Werner J; Bazhin AV
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells.
    Bianchi G; Borgonovo G; Pistoia V; Raffaghello L
    Histol Histopathol; 2011 Jul; 26(7):941-51. PubMed ID: 21630223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer.
    Yamauchi Y; Safi S; Blattner C; Rathinasamy A; Umansky L; Juenger S; Warth A; Eichhorn M; Muley T; Herth FJF; Dienemann H; Platten M; Beckhove P; Utikal J; Hoffmann H; Umansky V
    Am J Respir Crit Care Med; 2018 Sep; 198(6):777-787. PubMed ID: 29617574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy.
    Krishnamoorthy M; Gerhardt L; Maleki Vareki S
    Cells; 2021 May; 10(5):. PubMed ID: 34065010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myeloid-derived suppressor cells-a new therapeutic target to overcome resistance to cancer immunotherapy.
    Chesney JA; Mitchell RA; Yaddanapudi K
    J Leukoc Biol; 2017 Sep; 102(3):727-740. PubMed ID: 28546500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment.
    Hofer F; Di Sario G; Musiu C; Sartoris S; De Sanctis F; Ugel S
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies.
    Shou D; Wen L; Song Z; Yin J; Sun Q; Gong W
    Oncotarget; 2016 Sep; 7(39):64505-64511. PubMed ID: 27542274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid regulatory cells in tumor spreading and metastasis.
    Keskinov AA; Shurin MR
    Immunobiology; 2015 Feb; 220(2):236-42. PubMed ID: 25178934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunomodulatory role of exosomal microRNA networks in the crosstalk between tumor-associated myeloid-derived suppressor cells and tumor cells.
    Shokati E; Safari E
    Int Immunopharmacol; 2023 Jul; 120():110267. PubMed ID: 37276829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.